A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling

被引:81
作者
Yang, RB [1 ]
Ng, CKD [1 ]
Wasserman, SM [1 ]
Kömüves, LG [1 ]
Gerritsen, ME [1 ]
Topper, JN [1 ]
机构
[1] Millennium Pharmaceut Inc, Dept Cardiovasc Res, San Francisco, CA 94080 USA
关键词
D O I
10.1074/jbc.M305022200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously utilized a combination of high throughput sequencing and genome-wide microarray profiling analyses to identify novel cell-surface proteins expressed in human umbilical vein endothelial cells. One gene identified by this approach encodes a type I transmembrane receptor that shares sequence homology with the intracellular domain of members of the interleukin-17 (IL-17) receptor family. Real-time quantitative PCR and Northern analyses revealed that this gene is highly expressed in human umbilical vein endothelial cells and in several highly vascularized tissues such as kidney, colon, skeletal muscle, heart, and small intestine. In addition, we also found that it is also highly expressed in the ductal epithelial cells of human salivary glands, seminal vesicles, and the collecting tubules of the kidney by in situ hybridization. This putative receptor, which we have termed human SEF (hSEF), is also expressed in a variety of breast cancer tissues. In co-immunoprecipitation assays, this receptor is capable of forming homomeric complexes and can interact with fibroblast growth factor (FGF) receptor 1. Overexpression of this receptor inhibits FGF induction of an FGF-responsive reporter gene in human 293T cells. This appears to occur as a result of specific inhibition of p42/p44 ERK in the absence of upstream MEK inhibition. This inhibitory effect is dependent upon a functional intracellular domain since deletion mutants missing the IL-17 receptor-like domain lack this inhibitory effect. These findings are consistent with the recent discovery of the zebrafish homologue, Sef ( similar expression to fgf genes), which specifically antagonizes FGF signaling when ectopically expressed in zebrafish or Xenopus laevis embryos. Based on sequence and functional similarities, this novel IL-17 receptor homologue represents a potential human SEF and is likely to play critical roles in endothelial or epithelial functions such as proliferation, migration, and angiogenesis.
引用
收藏
页码:33232 / 33238
页数:7
相关论文
共 50 条
[1]  
Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1
[2]   Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin-4-induced activation of human keratinocytes [J].
Albanesi, C ;
Scarponi, CS ;
Cavani, A ;
Federici, M ;
Nasorri, F ;
Girolomoni, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (01) :81-87
[3]   IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines [J].
Albanesi, C ;
Scarponi, C ;
Sebastiani, S ;
Cavani, A ;
Federici, M ;
De Pità, O ;
Puddu, P ;
Girolomoni, G .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1395-1402
[4]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[5]  
Antonysamy MA, 1999, J IMMUNOL, V162, P577
[6]   Evidence for a role of IL-17 in alloimmunity: A novel IL-17 antagonist promotes heart graft survival [J].
Antonysamy, MA ;
Fanslow, WC ;
Fu, F ;
Li, W ;
Qian, S ;
Troutt, AB ;
Thomson, AW .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :93-93
[7]  
Brown RE, 2002, ANN CLIN LAB SCI, V32, P12
[8]   IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis [J].
Chabaud, M ;
Lubberts, E ;
Joosten, L ;
van den Berg, W ;
Miossec, P .
ARTHRITIS RESEARCH, 2001, 3 (03) :168-177
[9]   Regulation of endothelial cell survival and apoptosis during angiogenesis [J].
Chavakis, E ;
Dimmeler, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (06) :887-893
[10]  
Cines DB, 1998, BLOOD, V91, P3527